Inflammatory Breast Cancer: Results of Antracycline-Based Neoadjuvant Chemotherapy
- 1 March 2003
- journal article
- research article
- Published by Hindawi Limited in The Breast Journal
- Vol. 9 (2) , 79-85
- https://doi.org/10.1046/j.1524-4741.2003.09204.x
Abstract
Twenty-three patients with inflammatory breast cancer treated with a combined modality approach including anthracycline-based induction chemotherapy-surgery-chemotherapy-radiotherapy were r...Keywords
This publication has 27 references indexed in Scilit:
- Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcomeBreast Cancer Research and Treatment, 2001
- Thymidine Labeling Index in Breast Cancer PrognosisThe Breast Journal, 1998
- Management of locally advanced carcinoma of the breast: II. Inflammatory carcinomaCancer, 1994
- Long-term results of a combined modality approach in treating inflammatory carcinoma of the breastThe American Journal of Surgery, 1991
- Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced diseaseCancer, 1989
- Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysisCancer, 1987
- Combined modality treatment of inflammatory breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Mastectomy in the management of patients with inflammatory breast cancerJournal of Surgical Oncology, 1983
- Inflammatory carcinoma of the breastThe American Journal of Surgery, 1978
- Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomyCancer, 1976